742 - A Double-Blind, Randomized, Placebo-Controlled Trial of Fecal Microbiota Transplantation Capsules (FMTC) for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
The DOI matches its Crossref record.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, a separate multicenter RCT189 comparing FMT capsules to placebo in patients with diarrhea-predominant IBS was unable to demonstrate significant symptom relief at three months with FMT, although subgroup analysis suggested patients with post-infectious IBS experienced greater improvement with FMT compared to placebo (p=0.09).”
From The gut Microbiome in adult and pediatric functional gastrointestinal disorders (2019) · cites this paper as [189]
Citations
Cited by
Human gut microbiota/microbiome in health and diseases: a review
Gomaa, E. Z. (2020) · Antonie van Leeuwenhoek · doi:10.1007/s10482-020-01474-7 · Cited by 1,294
“…irritable bowel syndrome, inflammatory bowel disease, insulin resistance, obesity, autism, diarrhea, allergic disorders, metabolic syndrome, colon cancer, anti-tumor immunity, neuropsychiatric conditions and Parkinson’s disease (Holvoet et al. 2017; Johnsen et al. 2018; Aroniadis et al. 2018).”
BackgroundACG Clinical Guideline: Management of Irritable Bowel Syndrome
Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001036 · Cited by 893
Factors affecting the composition of the gut microbiota, and its modulation
Hasan, N., & Yang, H. (2019) · PeerJ · doi:10.7717/peerj.7502 · Cited by 755
“, 2018), irritable bowel syndrome (Pinn, Aroniadis & Brandt, 2014;Gibson & Roberfroid, 1995; Borody et al., 2004; Holvoet et al., 2017; Mizuno et al., 2017; Aroniadis et al., 2018; Halkjær et al., 2018; Johnsen et al., 2018) constipation (Tian et al.”
BackgroundThe Super-Donor Phenomenon in Fecal Microbiota Transplantation
Wilson, B. C., Vatanen, T., Cutfield, W. S., & O'Sullivan, J. M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00002 · Cited by 413
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications.
Allegretti, J. R., Mullish, B. H., Kelly, C., & Fischer, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31266-8 · Cited by 358
Metadata
- Authors
- Aroniadis, O. C., Brandt, L. J., Oneto, C., Feuerstadt, P., Sherman, A., Wolkoff, A. W., Downs, I. A., Zanetti-Yabur, A., Ramos, Y., Cotto, C. L., Kassam, Z., Elliott, R. J., Rosenbaum, R., Budree, S., Sadovsky, R. G., Timberlake, S., Swanson, P., Kim, M., & Keller, M. J.
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 154
- Issue
- 6
- Pages
- S-154-S-155
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2800264530
- Cited by
- 27
- References
- 0
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 9 · 2019: 8 · 2018: 3
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Gastroenterology (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- fecal microbiota transplantation, diarrhea-predominant irritable bowel syndrome, pediatric Crohn's disease, age of onset, interferon-gamma, alpha-defensins, Paneth cells, NOD2, ATG16L1, Enterobacteriaceae, dysbiosis, host-microbe interactions, 16S rRNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 742 - A Double-Blind, Randomized, Placebo-Controlled Trial of Fecal Microbiota Transplantation Capsules (FMTC) for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D). https://app.cochat.ai/papers/10.1016/s0016-5085(18)30932-6
- The paper
- Aroniadis, O. C., Brandt, L. J., Oneto, C., Feuerstadt, P., Sherman, A., Wolkoff, A. W., Downs, I. A., Zanetti-Yabur, A., Ramos, Y., Cotto, C. L., Kassam, Z., Elliott, R. J., Rosenbaum, R., Budree, S., Sadovsky, R. G., Timberlake, S., Swanson, P., Kim, M., & Keller, M. J. (2018). 742 - A Double-Blind, Randomized, Placebo-Controlled Trial of Fecal Microbiota Transplantation Capsules (FMTC) for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D). Gastroenterology. https://doi.org/10.1016/s0016-5085(18)30932-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.